• 1214 Citations
  • 12 h-Index
1989 …2017
If you made any changes in Pure these will be visible here soon.

Research Output 1989 2017

Article
37 Citations (Scopus)

A defective non-LTR retrotransposon is dispersed throughout the genome of the silkworm, Bombyx mori

Ogura, T., Okano, K., Tsuchida, K., Miyajima, N., Tanaka, H., Takada, N., Izumi, S., Tomino, S. & Maekawa, H., 1994 Sep, In : Chromosoma. 103, 5, p. 311-323 13 p.

Research output: Contribution to journalArticle

80 Citations (Scopus)

Adenylate cyclases in yeast: A comparison of the genes from Schizosaccharomyces pombe and Saccharomyces cerevisiae

Yamawaki-Kataoka, Y., Tamaoki, T., Choe, H. R., Tanaka, H. & Kataoka, T., 1989, In : Proceedings of the National Academy of Sciences of the United States of America. 86, 15, p. 5693-5697 5 p.

Research output: Contribution to journalArticle

80 Citations (Scopus)

Adenylate cyclases in yeast; A comparison of the genes from Schizosaccharomyces pombe and Saccharomyces

Yamawaki-Kataoka, Y., Tamaoki, T., Choe, H-R., Tanaka, H. & Kotaoka, T., 1989 Aug 1, In : Proc. Natl. Acad. Sci. USA. p. 5693-5697

Research output: Contribution to journalArticle

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor y-activating properties.

Reginato, M. J., Krakow, S. T. B., Minami, C., Ishii, S., Tanaka, H. & Lazar, M. A., 1998 Dec 4, In : THE JOURNAL OF BIOLOGICAL CHEMISTRY. p. 32679-32684

Research output: Contribution to journalArticle

174 Citations (Scopus)

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γ-activating properties

Reginato, M. J., Bailey, S. T., Krakow, S. L., Minami, C., Ishii, S., Tanaka, H. & Lazar, M. A., 1998 Dec 4, In : Journal of Biological Chemistry. 273, 49, p. 32679-32684 6 p.

Research output: Contribution to journalArticle

Peroxisome Proliferator-Activated Receptors
Hypoglycemic Agents
Thiazolidinediones
rosiglitazone
Chemical activation

AUTM Technology Transfer Practice Manual, 3rd Edition, Volume Three, Part Two、 “The ownership of intellectual property rights which are raised through the collaboration between Universities and Industry in Japan”

Ku, K., Bres, O., Munson, F., Breit, G. G., Licata, J. M., White, A. E., Heller, P., Sparks, R. L., Roberts, J. S., Fasse, J. P., Kaiser, E., Murphy, S. L., Sibley, K. D., Burmania, J., Stewart, P. B., Jenkins, R. E., Kneller, R., Hideho, TANAKA., Chikako, SAOTOME. & Tanaka, H., 2008 Jan 1, In : Default journal.

Research output: Contribution to journalArticle

COMPARATIVE EFFECTS OF THIAZOLIDINEDIONES ON PLASMA GLUCOSE AND TRIGLYCERIDES IN A MOUSE MODEL OF DIABETES

Shinnichi, ISHII., Hideho, TANAKA., Muneshige, SIRAHI. & Tanaka, H., 2001 Sep 12, In : Default journal.

Research output: Contribution to journalArticle

EFFECT OF REPEATED ADMINISTRATION OF RWJ241947/MCC-555, A NOVEL INSULIN SENSITIZER, ON SERUM LIPOPROTEIN LEVELS IN db/db MICE

Muneshige, SHIRAISHI., Shinichi, ISHI., Hideho, TANAKA. & Tanaka, H., 2001 Sep 12, In : Default journal.

Research output: Contribution to journalArticle

53 Citations (Scopus)

Improved metabolic status and insulin sensitivity in obese fatty(fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555

Upton, R., Widdowson, P. S., Ishii, S., Tanaka, H. & Williams, G., 1998 Dec 1, In : British Journal of Pharmacology. p. 1708-1714

Research output: Contribution to journalArticle

53 Citations (Scopus)

Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555

Upton, R., Widdowson, P. S., Ishii, S., Tanaka, H. & Williams, G., 1998, In : British Journal of Pharmacology. 125, 8, p. 1708-1714 7 p.

Research output: Contribution to journalArticle

IP Management System Compatible with Increasingly Mobile Research Population

Tanaka, H., 2007, In : IP Prism. 5, 56, p. 13-22 10 p.

Research output: Contribution to journalArticle

Management of medical intellectual property and publication at universities,

Chikako, SAOTOME. & Tanaka, H., 2010, In : Journal of Health Care and Society. 20, 2, p. 155-167 13 p.

Research output: Contribution to journalArticle

Management of technology education in the global era

Tanaka, H., 2012, In : Development Engineering. 32, 1, p. 77-81 5 p.

Research output: Contribution to journalArticle

MCC-555: A highly potent thiazolidinedione lacking hematological and cardiac side-effects

Shinichi, ISHII., Masahiko, WASAKI., Takayuki, OHE., Hiroaki, UENO., Hideho, TANAKA. & Tanaka, H., 1996 Jun 8, In : Default journal.

Research output: Contribution to journalArticle

106 Citations (Scopus)

Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes

Hiraki, Y., Tanaka, H., Inoue, H., Kondo, J., Kamizono, A. & Suzuki, F., 1991 Mar 29, In : Biochemical and Biophysical Research Communications. 175, 3, p. 971-977 7 p.

Research output: Contribution to journalArticle

Cloning
Cartilage
Glycosylation
Fibroblast Growth Factor 2
Bioactivity

Molecular cloning of a novel cartilage-specific matrix, chondromodulin-I

Yuji, HIRAKI., Hideho, TANAKA., Hiroyuki, INOUE., Rujio, K. J. & Tanaka, H., 1991 Aug 1, In : Default journal.

Research output: Contribution to journalArticle

Pathological significance of ganglioside in non-insulin dependent diabetes mellitus (NIDDM)

Hideho, TANA., Hisao, N. & Tanaka, H., 1994 Jun 1, In : Default journal.

Research output: Contribution to journalArticle

Intellectual property

Strategic Intellectual Property Management for Competitive Advantage

Translated title of the contribution: Strategic Intellectual Property Management for Competitive AdvantageTanaka, H., 2011 Aug 1, In : Kyokai Joho Imeji Zasshi/Journal of the Institute of Image Information and Television Engineers. 65, 8, p. 1149 1152 p.

Research output: Contribution to journalArticle

42 Citations (Scopus)

The development of overt diabetes in young Zucker Diabetic Fatty(ZDF) rats and the effects of chronic MCC-555 treatment

Pickavance, L., Widdowson, P. S., King-P, K-P., Ishii, S., Tanaka, H. & Williams, G., 1998 Oct 1, In : British Journal of Pharmacology. p. 767-770

Research output: Contribution to journalArticle

42 Citations (Scopus)

The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment

Pickavance, L., Widdowson, P. S., King, P., Ishii, S., Tanaka, H. & Williams, G., 1998, In : British Journal of Pharmacology. 125, 4, p. 767-770 4 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes

Liu, L. S., Tanaka, H., Ishii, S. & Eckel, J., 1998, In : Endocrinology. 139, 11, p. 4531-4539 9 p.

Research output: Contribution to journalArticle

The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis

Eckel, J., Hideho, TANAKA., Liu, ISHII. S. & Tanaka, H., 1998 Jun 13, In : Default journal.

Research output: Contribution to journalArticle

The pioneer of MOT in Japan

Tanaka, H., 2014, In : Development Engineering. 34, 1, p. 21-24 4 p.

Research output: Contribution to journalArticle

256 Citations (Scopus)

Visualization of dystrophic muscle fibers in Mdx mouse by vital staining with Evans blue: Evidence of apoptosis in dystrophin-deficient muscle

Matsuda, R., Nishikawa, A. & Tanaka, H., 1995, In : Journal of Biochemistry. 118, 5, p. 959-964 6 p.

Research output: Contribution to journalArticle

Evans Blue
Dystrophin
Cell death
Muscle
Visualization
256 Citations (Scopus)
Chapter

イノベーション入門 戦略的技術経営入門4

Tanaka, H., 2016 Jan 28, 芝浦工業大学MOT. 芙蓉書房出版, p. 43-75

Research output: Chapter in Book/Report/Conference proceedingChapter

エンジニア・サバイバルのすすめ 戦略的技術経営入門4

Tanaka, H., 2014 Nov 29, 芝浦工業大学MOT. 芙蓉書房出版, p. 45-59

Research output: Chapter in Book/Report/Conference proceedingChapter

戦略的技術経営入門 グローバルに考えると明日が見える

Tanaka, H., 2012 Sep 1, 芝浦工業大学MOT. 芙蓉書房出版

Research output: Chapter in Book/Report/Conference proceedingChapter

戦略的技術経営入門2 いまこそイノベーション

Tanaka, H., 2013 Sep 25, 芝浦工業大学MOT. 芙蓉書房出版, p. 153-167

Research output: Chapter in Book/Report/Conference proceedingChapter

Conference contribution

Industrial & Academic Collaboration in Japan

Tanaka, H., 2008 Nov 18, Korea Invention Promotion Association.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Preadaptation Strategy in Technology Management

Tanaka, H., 2017 May 14, International Association for Management if Technology: IAMOT 2017 Conference Proceedings.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Discussion paper

Intellectual Property and Firm Performance in High-Tech Start-ups

Translated title of the contribution: Intellectual Property and Firm Performance in High-Tech Start-upsTanaka, H., Inamura, K. & Nagaoka, K., 2011 Jul 7, Shibaura MOT Discussion Paper.

Research output: Working paperDiscussion paper

Patent

Chondromodulin-II protein

Tanaka, H., Suzuki, F. & Yuji, HIRAKI., 1992 Aug 6, IPC No. C07K 14/51, Patent No. EP0526883B1

Research output: Patent

Chondromodulin-I protein

Tanaka, H., suzuki, F. & Yuji, HIRAKI., 1991 Aug 23, IPC No. C12N 15/16, Patent No. EP0473080B1

Research output: Patent

筋ジストロフィー治療薬

Tanaka, H. & matsuda, R., 1994 Dec 5

Research output: Patent